SCHEMBL21625007

SCHEMBL21625007

O=C(O)N1CCC2(CCC(NS(=O)(=O)CC3CC3)O2)CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21625015 0.93 MGLL (0.31) MGLL
SCHEMBL21625009 0.80 MGLL (0.37) MGLL
SCHEMBL21625014 0.78 MGLL (0.44) MGLL
SCHEMBL20399926 0.75 MGLL (0.46) MGLL
SCHEMBL18446121 0.72 MGLL (0.46) MGLL
SCHEMBL20399264 0.68 MGLL (0.48) MGLL
SCHEMBL360600 0.68 — —
SCHEMBL21636210 0.65 MGLL (0.43) MGLL
SCHEMBL360415 0.65 PRKCA (0.41) —
SCHEMBL21625008 0.64 MGLL (0.39) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3823723-A1 HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS Pfizer Inc. (US) 2021-05-26 — — EP disclosed
WO-2020016710-A1 HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS PFIZER INC. (US) 2020-01-23 — — WO disclosed
Send feedback